SCHEMBL25848266

SCHEMBL25848266

C=C(C)C(=O)OC1CCC(Oc2ccc3cc(-c4ccc(CCCCC)cc4OC(F)(F)F)c(=O)oc3c2)C1C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STS P08842 1/20 0.34
MAOB P27338 3/20 0.33
MAOA P21397 2/20 0.33
KDM4E B2RXH2 2/20 0.32
GLA P06280 2/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
NOD2 Q9HC29 1/20 0.32
NPC1 O15118 4/20 0.31
RAB9A P51151 4/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
PTPN7 P35236 1/20 0.31
S1PR1 P21453 1/20 0.31
S1PR3 Q99500 1/20 0.31
TERT O14746 3/20 0.31
HSD11B1 P28845 1/20 0.30
FPR1 P21462 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22624935 0.93 STS (0.34) STSMAOBMAOAKDM4EGLA
SCHEMBL25848269 0.92 KDM4E (0.39) MAOBMAOAKDM4EGLAALDH1A1
SCHEMBL25848265 0.90 THRB (0.37) STSMAOBMAOAKDM4EGLA
SCHEMBL25848256 0.89 NPC1 (0.35) MAOBMAOAKDM4EGLAALDH1A1
SCHEMBL25848258 0.89 MAOB (0.37) MAOBMAOAKDM4EGLAALDH1A1
SCHEMBL25848273 0.87 MAOB (0.39) MAOBMAOAKDM4EGLAALDH1A1
SCHEMBL25848290 0.87 STS (0.33) STSMAOBMAOAKDM4EGLA
SCHEMBL22624922 0.87 KDM4E (0.38) MAOBMAOAKDM4EGLAALDH1A1
SCHEMBL22625305 0.86 STS (0.33) STSMAOBMAOAKDM4EGLA
SCHEMBL21734937 0.84 S1PR1 (0.36) S1PR1S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702396-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 STS 4081/4885MAOB 3207/4885MAOA 2922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.